Search Tufts Medicine

Dr. Michael House Receives Grand Prize for Novel Device to Prevent Preterm Birth.

Poor nutrition is devastating the health of American families. A prescription produce program, from Tufts Medicine’s Mother Infant Research Institute and the Friedman School of Nutrition Science and Policy at Tufts University, is delivering nutritious foods and a healthy start to Massachusetts families.

Dr. Perrie O’Tierney-Ginn receives Liley Lectureship at 2023 PAS Meeting.

MIRI PI Dr. Michael House and his team members received a COVID-19 Rapid Response SeeD Funding Grant. This new funding program is intended to fast track innovative research proposals that directly address the urgent needs of the COVID-19 pandemic.

MIRI PI Patrick Catalano, MD, has been awarded an R21 from the NIH/NICHD as Multi-Site PI for a two-year study entitled, “Impact of a Postpartum Lifestyle Intervention on Lactation Outcomes, Breastmilk Composition and Infant Growth.”

Dr. Elizabeth Yen, a neonatologist at Tufts Medical Center, has received the 2021 award for Outstanding Young Investigator.

The Department of Obstetrics + Gynecology cares for individuals through all transformative stages of life: puberty, pregnancy and menopause. These experiences are best supported by clinical expertise and compassionate care, qualities that are deeply woven within the fabric of our department. Through our research labs and residency programs, we strive to help the next generation of reproductive health professionals do the same.

Since the late 19th century, the Department of Pediatrics has been improving and redefining pediatric care, research and training.

A new, three-year NIH grant will expand Dr. Elizabeth Yen's research and initial pilot study findings about the effects of prenatal opioid exposure in an infant's first year of life.

MIRI Principal Investigator Michael House, MD will be collaborating in a study with funding from the CTSI Pilot Study Program.

A national clinical trial led by Tufts Children’s Hospital researchers has found that both targeted genome sequencing and whole genome sequencing may help diagnose genetic abnormalities in neonates and infants. However, the technology and interpretations of results continue to have significant limitations that require further research and understanding.